scispace - formally typeset
D

Dennis C. Dean

Researcher at Merck & Co.

Publications -  76
Citations -  5370

Dennis C. Dean is an academic researcher from Merck & Co.. The author has contributed to research in topics: Radioligand & Receptor. The author has an hindex of 27, co-authored 76 publications receiving 5169 citations. Previous affiliations of Dennis C. Dean include United States Military Academy.

Papers
More filters
Journal ArticleDOI

Transport of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin by Human Organic Anion Transporter 3, Organic Anion Transporting Polypeptide 4C1, and Multidrug Resistance P-glycoprotein

TL;DR: The data indicate that sitagliptin is unlikely to be a perpetrator of drug-drug interactions with Pgp, hOAT1, or hOat3 substrates at clinically relevant concentrations, and the effects may not be clinically meaningful, due to the high safety margin of sitgliptin.
Journal ArticleDOI

Evaluation of ubiquinone concentration and mitochondrial function relative to cerivastatin-induced skeletal myopathy in rats.

TL;DR: It is suggested that neither mitochondrial injury, nor a decrease in muscle ubiquinone levels, is the primary cause of skeletal myopathy in cerivastatin-dosed rats.
Journal ArticleDOI

Structural Requirements for the Activation of the Human Growth Hormone Secretagogue Receptor by Peptide and Nonpeptide Secretagogues

TL;DR: Antibodies raised against an intracellular and extracellular domain of the GH secretagogue receptor (GHS-R) confirmed that its topological orientation in the lipid bilayer is as predicted for G protein-coupled receptors with seven transmembrane domains.
Journal Article

Metabolites of caspofungin acetate, a potent antifungal agent, in human plasma and urine.

TL;DR: Caspofungin acetate is a semisynthetic pneumocandin derivative being developed as a parenteral antifungal agent with broad-spectrum activity against systemic infections such as those caused by Candida and Aspergillus species.